Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021

Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021

Bibliographic Details
Main Authors:	José A. G. Agúndez, Elena García-Martín
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-04-01
Series:	Frontiers in Pharmacology
Subjects:	Pharmacogenetics (PGx) Pharmacogenomics (PGx) combinatorial & high-throughput methods next generating sequencing clinical practice NAT1 acetylation
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.907131/full

Similar Items

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
by: Nathalie K. Zgheib, et al.
Published: (2020-08-01)

Editorial: Pharmacogenomics in neglected populations
by: Mariana R. Botton, et al.
Published: (2022-11-01)

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
by: Wojciech Miltyk, et al.
Published: (2022-11-01)

Computational pharmacogenotype extraction from clinical next-generation sequencing
by: Tyler Shugg, et al.
Published: (2023-07-01)

Translating pharmacogenomics into clinical decisions: do not let the perfect be the enemy of the good
by: Kristi Krebs, et al.
Published: (2019-08-01)

High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile
by: Blake Bartlett, et al.
Published: (2023-06-01)

Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
by: Mi Seon Youn, et al.
Published: (2024-12-01)

Editorial: Population Pharmacogenomics (PGx): From Variant Identification to Clinical Implementation
by: Masahiro Hiratsuka, et al.
Published: (2021-08-01)

Editorial: Precision psychiatry from a pharmacogenetics perspective
by: Lisa C. Brown, et al.
Published: (2023-03-01)

The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature
by: Abdallah Alzoubi, et al.
Published: (2024-01-01)

Translating Pharmacogenetics and Pharmacogenomics to the Clinic: Progress in Human and Veterinary Medicine
by: Deirdre P. Campion, et al.
Published: (2019-02-01)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
by: Napatrupron Koomdee, et al.
Published: (2022-04-01)

Pharmacogenomics and health disparities, are we helping?
by: Sherin Shaaban, et al.
Published: (2023-01-01)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2023-08-01)

Genotyping of Patients with Adverse Drug Reaction or Therapy Failure: Database Analysis of a Pharmacogenetics Case Series Study
by: Bollinger A, et al.
Published: (2023-07-01)

Editorial: Pharmacogenetics of psychiatric disorders
by: Sarah Allegra, et al.
Published: (2025-01-01)

From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt
by: Fadya M. Elgarhy, et al.
Published: (2024-07-01)

Efficacy and safety of pharmacogenomic-guided antidepressant prescribing in patients with depression: an umbrella review and updated meta-analysis
by: Kiflu G. Tesfamicael, et al.
Published: (2024-07-01)

Editorial: Utilization of pharmacogenomics in clinical practice
by: Apostolos Papachristos, et al.
Published: (2024-08-01)

Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics
by: Therdpong Tempark, et al.
Published: (2022-04-01)

Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System
by: Pawel Mroz, et al.
Published: (2021-10-01)

Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
by: Alireza Tafazoli, et al.
Published: (2023-08-01)

Pharmacogenomics at the post-pandemic: If not now, then when?
by: Zeina N. Al-Mahayri
Published: (2022-09-01)

Pharmacogenomics-assisted treatment versus standard of care in schizophrenia: a systematic review and meta-analysis
by: Saibal Das, et al.
Published: (2024-10-01)

Editorial: Insights in pharmacogenetics and pharmacogenomics: 2023
by: José A. G. Agúndez, et al.
Published: (2025-01-01)

Editorial: NSAIDs Pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2021-11-01)

Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives
by: Kholoud Bastaki, et al.
Published: (2024-03-01)

Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024-02-01)

Real‐World Utilization of Medications With Pharmacogenetic Recommendations in Older Adults: A Scoping Review
by: Bella D. Ianni, et al.
Published: (2025-02-01)

Androgen receptor-mediated pharmacogenomic expression quantitative trait loci: implications for breast cancer response to AR-targeting therapy
by: Huanyao Gao, et al.
Published: (2024-07-01)

Pharmacogenomics Biomarkers of Soft Tissue Sarcoma Therapies
by: Chiara Caruso, et al.
Published: (2020-04-01)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
by: Wittwer NL, et al.
Published: (2022-11-01)

Editorial: The Potential of Machine Learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology
by: Augusto Garcia-Agundez, et al.
Published: (2022-05-01)

Impact and Enablers of Pharmacogenetic-Informed Treatment Decisions—A Longitudinal Mixed-Methods Study Exploring the Patient Perspective
by: Anna Bollinger, et al.
Published: (2025-01-01)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
by: Augusto Garcia-Agundez, et al.
Published: (2023-08-01)

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report
by: Jeiziner C, et al.
Published: (2022-05-01)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01)

Virtual twin for healthcare management
by: Thomas M. Polasek, et al.
Published: (2023-09-01)

Genetic polymorphisms influencing deferasirox pharmacokinetics, efficacy, and adverse drug reactions: a systematic review and meta-analysis
by: Kittika Yampayon, et al.
Published: (2023-05-01)